Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma

Neuro Oncol. 2024 Sep 5;26(9):1660-1669. doi: 10.1093/neuonc/noae073.

Abstract

Background: Survival is variable in patients with glioblastoma IDH wild-type (GBM), even after comparable surgical resection of radiographically detectable disease, highlighting the limitations of radiographic assessment of infiltrative tumor anatomy. The majority of postsurgical progressive events are failures within 2 cm of the resection margin, motivating supramaximal resection strategies to improve local control. However, which patients benefit from such radical resections remains unknown.

Methods: We developed a predictive model to identify which IDH wild-type GBMs are amenable to radiographic gross-total resection (GTR). We then investigated whether GBM survival heterogeneity following GTR is correlated with microscopic tumor burden by analyzing tumor cell content at the surgical margin with a rapid qPCR-based method for detection of TERT promoter mutation.

Results: Our predictive model for achievable GTR, developed on retrospective radiographic and molecular data of GBM patients undergoing resection, had an area under the curve of 0.83, sensitivity of 62%, and specificity of 90%. Prospective analysis of this model in 44 patients found that 89% of patients were correctly predicted to achieve a residual volume (RV) < 4.9cc. Of the 44 prospective patients undergoing rapid qPCR TERT promoter mutation analysis at the surgical margin, 7 had undetectable TERT mutation, of which 5 also had a GTR (RV < 1cc). In these 5 patients at 30 months follow-up, 75% showed no progression, compared to 0% in the group with TERT mutations detected at the surgical margin (P = .02).

Conclusions: These findings identify a subset of patients with GBM that may derive local control benefits from radical resection to undetectable molecular margins.

Keywords: GBM; TERT promoter; extent of resection; postoperative survival; supramaximal resection.

MeSH terms

  • Adult
  • Aged
  • Brain Neoplasms* / diagnostic imaging
  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / mortality
  • Brain Neoplasms* / pathology
  • Brain Neoplasms* / surgery
  • Female
  • Follow-Up Studies
  • Glioblastoma* / diagnostic imaging
  • Glioblastoma* / genetics
  • Glioblastoma* / mortality
  • Glioblastoma* / pathology
  • Glioblastoma* / surgery
  • Humans
  • Isocitrate Dehydrogenase* / genetics
  • Male
  • Margins of Excision*
  • Middle Aged
  • Mutation*
  • Neurosurgical Procedures / methods
  • Prognosis
  • Promoter Regions, Genetic
  • Prospective Studies
  • Retrospective Studies
  • Survival Rate
  • Telomerase / genetics

Substances

  • Isocitrate Dehydrogenase
  • TERT protein, human
  • Telomerase
  • IDH1 protein, human